UiPath (NYSE:PATH) Stock Price Up 1.1%

UiPath Inc. (NYSE:PATH) was up 1.1% during mid-day trading on Friday . The stock traded as high as $19.88 and last traded at $19.51. Approximately 1,456,681 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 8,436,063 shares. The stock had previously closed at $19.30.

Analyst Upgrades and Downgrades

PATH has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upgraded shares of UiPath from a “neutral” rating to an “overweight” rating and boosted their price target for the company from $22.00 to $28.00 in a research report on Thursday, March 14th. KeyCorp started coverage on UiPath in a research note on Monday, April 8th. They issued an “overweight” rating and a $27.00 target price on the stock. Truist Financial restated a “buy” rating and issued a $32.00 price objective on shares of UiPath in a research report on Wednesday, March 20th. BMO Capital Markets lifted their target price on shares of UiPath from $24.00 to $28.00 and gave the company a “market perform” rating in a research report on Thursday, March 14th. Finally, Wells Fargo & Company increased their price target on shares of UiPath from $24.00 to $25.00 and gave the stock an “equal weight” rating in a report on Thursday, March 14th. Nine investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $27.41.

UiPath Stock Performance

The firm has a 50-day moving average of $21.75 and a 200-day moving average of $21.65. The firm has a market capitalization of $11.08 billion, a P/E ratio of -114.55 and a beta of 1.01.

UiPath (NYSE:PATH) last issued its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The company had revenue of $405.25 million for the quarter, compared to the consensus estimate of $383.32 million. Equities analysts anticipate that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Activity at UiPath

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the stock in a transaction that occurred on Monday, February 5th. The stock was sold at an average price of $22.47, for a total value of $359,520.00. Following the completion of the sale, the chief financial officer now owns 103,505 shares in the company, valued at approximately $2,325,757.35. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders have sold a total of 72,000 shares of company stock worth $1,591,360 in the last 90 days. Company insiders own 31.03% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in the stock. Mark Sheptoff Financial Planning LLC purchased a new position in shares of UiPath during the fourth quarter valued at about $25,000. HighMark Wealth Management LLC bought a new position in shares of UiPath in the 4th quarter worth approximately $27,000. Cypress Capital Management LLC WY purchased a new position in shares of UiPath in the 4th quarter valued at approximately $29,000. GAMMA Investing LLC bought a new stake in shares of UiPath during the fourth quarter valued at approximately $36,000. Finally, FNY Investment Advisers LLC purchased a new stake in UiPath in the fourth quarter worth $40,000. 62.50% of the stock is currently owned by institutional investors.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.